av/eliem-therapeutics--big.svg

COM:ELIEMTX

Eliem Therapeutics

  • Stock

USD

Last Close

5.16

02/10 20:00

Market Cap

478.85M

Beta: -

Volume Today

802.69K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
gross profit
selling and marketing expenses
general and administrative expenses
677K
-
2.42M
258.20%
12.35M
409.28%
18.92M
53.21%
24.86M
31.41%
selling general and administrative expenses
677K
-
2.42M
258.20%
12.35M
409.28%
18.92M
53.21%
24.86M
31.41%
research and development expenses
4.02M
-
9.34M
132.45%
23.32M
149.65%
26.21M
12.40%
15.41M
41.21%
other expenses
914K
-
-11.64M
-
1.38M
111.81%
cost and expenses
4.70M
-
11.77M
150.57%
35.67M
203.15%
45.13M
26.53%
40.27M
10.77%
operating expenses
4.70M
-
11.77M
150.57%
35.67M
203.15%
45.13M
26.53%
40.27M
10.77%
interest expense
1.59M
-
ebitda
-1.93M
-
-2.87M
48.42%
-35.50M
1,138.73%
-43.65M
22.95%
-40.27M
7.73%
operating income
-7.45M
-
-20.93M
181.02%
-35.67M
70.48%
-45.13M
26.53%
-40.27M
10.77%
depreciation and amortization
5.51M
-
18.06M
227.45%
170K
99.06%
1.48M
772.94%
total other income expenses net
899K
-
257K
71.41%
-11.81M
4,694.55%
-109K
99.08%
5.16M
4,830.28%
income before tax
-6.55M
-
-20.67M
215.69%
-47.48M
129.73%
-45.24M
4.71%
-35.12M
22.38%
income tax expense
-2.75M
-
-9.16M
233.02%
109K
-
net income
-3.80M
-
-11.51M
203.13%
-47.48M
312.51%
-45.35M
4.48%
-35.12M
22.57%
weighted average shs out
6.84M
-
11.66M
70.57%
12.26M
5.14%
26.31M
114.60%
26.99M
2.57%
weighted average shs out dil
6.84M
-
11.66M
70.57%
12.26M
5.14%
26.31M
114.60%
26.99M
2.57%
eps
-0.56
-
-0.99
76.79%
-3.87
290.91%
-1.72
55.56%
-1.30
24.42%
epsdiluted
-0.56
-
-0.99
76.79%
-3.87
290.91%
-1.72
55.56%
-1.30
24.42%

All numbers in USD (except ratios and percentages)